Seres Therapeutics News

Oppenheimer Sticks to Its Buy Rating for Seres Therapeutics (MCRB)

TipRanksMar 6 07:55 ET

Seres Therapeutics (MCRB) Gets a Buy From TD Cowen

TipRanksMar 5 23:55 ET

Sell Rating on Seres Therapeutics Amid Underperforming Sales and Financial Challenges

TipRanksFeb 6 19:35 ET

Seres Therapeutics Analyst Ratings

BenzingaJan 16 10:35 ET

Oppenheimer Trims Seres Therapeutics Price Target to $9 From $10, Maintains Outperform Rating

MT NewswiresJan 16 09:47 ET

Analysts Offer Insights on Healthcare Companies: Cellectar Biosciences (CLRB) and Seres Therapeutics (MCRB)

TipRanksJan 9 12:00 ET

Goldman Sachs Maintains Sell on Seres Therapeutics, Lowers Price Target to $1.25

BenzingaNov 3, 2023 10:58 ET

Seres Therapeutics Analyst Ratings

BenzingaNov 3, 2023 10:57 ET

Oppenheimer Adjusts Seres Therapeutics Price Target to $10 From $12, Maintains Outperform Rating

MT NewswiresNov 3, 2023 09:41 ET

Oppenheimer Sticks to Its Buy Rating for Seres Therapeutics (MCRB)

TipRanksNov 3, 2023 08:13 ET

Buy Rating for Seres Therapeutics: A Review of Vowst's Success, Restructuring, and SER-155 Prospects

TipRanksNov 3, 2023 07:44 ET

Sell Rating on Seres Therapeutics Amidst Restructuring and Financing Risk Concerns

TipRanksNov 3, 2023 02:25 ET

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Irhythm Technologies (IRTC) and Seres Therapeutics (MCRB)

TipRanksNov 2, 2023 23:50 ET

Analysts' Top Healthcare Picks: Seres Therapeutics (MCRB), Phathom Pharmaceuticals (PHAT)

TipRanksNov 2, 2023 12:41 ET

Seres Therapeutics (MCRB) Receives a Sell From Goldman Sachs

TipRanksAug 9, 2023 15:15 ET

Analysts' Top Healthcare Picks: Seres Therapeutics (MCRB), Inmune Bio (INMB)

TipRanksAug 9, 2023 07:50 ET

Oppenheimer Assumes Seres Therapeutics at Outperform, Announces Price Target of $12

BenzingaJun 26, 2023 06:47 ET

Analysts Offer Insights on Healthcare Companies: Seres Therapeutics (MCRB) and Agenus (AGEN)

TipRanksMay 31, 2023 08:51 ET

Seres Therapeutics (MCRB) Gets a Buy From Chardan Capital

TipRanksMay 9, 2023 20:36 ET

Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), Masimo (MASI) and Seres Therapeutics (MCRB)

TipRanksMay 2, 2023 07:36 ET